The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Neuroaxonal Dystrophies

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Neuroaxonal Dystrophies


Psychiatry related information on Neuroaxonal Dystrophies


High impact information on Neuroaxonal Dystrophies

  • Treatment with low-dose insulin (to control for the transient glucose-lowering effects of IGF-I) failed to affect the frequency of ganglionic or mesenteric nerve neuroaxonal dystrophy or the severity of diabetes [7].
  • Our findings (under these experimental conditions) do not support a role for aminoguanidine-sensitive processes in the development of sympathetic neuroaxonal dystrophy in diabetic rats [8].
  • Chronic aminoguanidine therapy did not diminish the frequency or affect the ultrastructural appearance of neuroaxonal dystrophy in diabetic or age-matched control rat sympathetic ganglia after 7 or 10 months of continuous administration [8].
  • Effect of aminoguanidine on the frequency of neuroaxonal dystrophy in the superior mesenteric sympathetic autonomic ganglia of rats with streptozocin-induced diabetes [8].
  • Quantitative studies demonstrated that markedly swollen argyrophilic terminal axons (neuroaxonal dystrophy) containing large numbers of disorganized neurofilaments developed in the SMG but not SCG as a function of diabetes, increasing age, and gender (males were more severely affected than females) [9].

Chemical compound and disease context of Neuroaxonal Dystrophies


Biological context of Neuroaxonal Dystrophies


Anatomical context of Neuroaxonal Dystrophies


Gene context of Neuroaxonal Dystrophies


  1. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats. Schmidt, R.E., Plurad, S.B., Sherman, W.R., Williamson, J.R., Tilton, R.G. Diabetes (1989) [Pubmed]
  2. Amyloid beta precursor protein and ubiquitin epitopes in human and experimental dystrophic axons. Ultrastructural localization. Bacci, B., Cochran, E., Nunzi, M.G., Izeki, E., Mizutani, T., Patton, A., Hite, S., Sayre, L.M., Autilio-Gambetti, L., Gambetti, P. Am. J. Pathol. (1994) [Pubmed]
  3. Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes. Schmidt, R.E., Dorsey, D.A., Beaudet, L.N., Plurad, S.B., Parvin, C.A., Yarasheski, K.E., Smith, S.R., Lang, H.J., Williamson, J.R., Ido, Y. J. Neuropathol. Exp. Neurol. (2001) [Pubmed]
  4. Ictal and nonictal paroxysmal events in infantile neuroaxonal dystrophy: polygraphic study of a case. Santucci, M., Ambrosetto, G., Scaduto, M.C., Morbin, M., Tzolas, E.V., Rossi, P.G. Epilepsia (2001) [Pubmed]
  5. Mechanism of calcium entry during axon injury and degeneration. LoPachin, R.M., Lehning, E.J. Toxicol. Appl. Pharmacol. (1997) [Pubmed]
  6. Tyrosine kinase A-nerve growth factor receptor is antigenically present in dystrophic neurites from a variety of conditions but not in Alzheimer's disease. Marinelli, L., Cammarata, S., Nobbio, L., Schenone, A., Zaccheo, D., Angelini, G., Tabaton, M. Neurosci. Lett. (1999) [Pubmed]
  7. Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy. Schmidt, R.E., Dorsey, D.A., Beaudet, L.N., Plurad, S.B., Parvin, C.A., Miller, M.S. Am. J. Pathol. (1999) [Pubmed]
  8. Effect of aminoguanidine on the frequency of neuroaxonal dystrophy in the superior mesenteric sympathetic autonomic ganglia of rats with streptozocin-induced diabetes. Schmidt, R.E., Dorsey, D.A., Beaudet, L.N., Reiser, K.M., Williamson, J.R., Tilton, R.G. Diabetes (1996) [Pubmed]
  9. Effect of diabetes and aging on human sympathetic autonomic ganglia. Schmidt, R.E., Plurad, S.B., Parvin, C.A., Roth, K.A. Am. J. Pathol. (1993) [Pubmed]
  10. Effects of sorbinil, dietary myo-inositol supplementation, and insulin on resolution of neuroaxonal dystrophy in mesenteric nerves of streptozocin-induced diabetic rats. Schmidt, R.E., Plurad, S.B., Coleman, B.D., Williamson, J.R., Tilton, R.G. Diabetes (1991) [Pubmed]
  11. Inherited neuroaxonal dystrophy in C6 deficient rabbits. Giannini, C., Monaco, S., Kirschfink, M., Rother, K.O., Lorbacher de Ruiz, H., Nardelli, E., Bonetti, B., Salviati, A., Zanette, G.P., Rizzuto, N. J. Neuropathol. Exp. Neurol. (1992) [Pubmed]
  12. Stroke-like syndrome, mineralizing microangiopathy, and neuroaxonal dystrophy following intrathecal methotrexate therapy. Phanthumchinda, K., Intragumtornchai, T., Kasantikul, V. Neurology (1991) [Pubmed]
  13. Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy. Schmidt, R.E., Dorsey, D.A., Beaudet, L.N., Plurad, S.B., Williamson, J.R., Ido, Y. J. Neuropathol. Exp. Neurol. (1998) [Pubmed]
  14. Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype. Keulemans, J.L., Reuser, A.J., Kroos, M.A., Willemsen, R., Hermans, M.M., van den Ouweland, A.M., de Jong, J.G., Wevers, R.A., Renier, W.O., Schindler, D., Coll, M.J., Chabas, A., Sakuraba, H., Suzuki, Y., van Diggelen, O.P. J. Med. Genet. (1996) [Pubmed]
  15. Differential effect of chronic vitamin E deficiency on the development of neuroaxonal dystrophy in rat gracile/cuneate nuclei and prevertebral sympathetic ganglia. Schmidt, R.E., Coleman, B.D., Nelson, J.S. Neurosci. Lett. (1991) [Pubmed]
  16. Cytoskeletal changes and ubiquitin expression in dystrophic axons of Seitelberger's disease. Moretto, G., Sparaco, M., Monaco, S., Bonetti, B., Rizzuto, N. Clin. Neuropathol. (1993) [Pubmed]
  17. Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome). Gordon, N. Eur. J. Paediatr. Neurol. (2002) [Pubmed]
  18. Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TrkA content of prevertebral and paravertebral rat sympathetic ganglia. Schmidt, R.E., Dorsey, D.A., Roth, K.A., Parvin, C.A., Hounsom, L., Tomlinson, D.R. Brain Res. (2000) [Pubmed]
  19. Infantile neuroaxonal dystrophy and pantothenate-kinase-associated neurodegeneration: locus heterogeneity. Hörtnagel, K., Nardocci, N., Zorzi, G., Garavaglia, B., Botz, E., Meitinger, T., Klopstock, T. Neurology (2004) [Pubmed]
  20. Transganglionic neuropeptide Y response to sciatic nerve injury in young and aged rats. Ohara, S., Roth, K.A., Beaudet, L.N., Schmidt, R.E. J. Neuropathol. Exp. Neurol. (1994) [Pubmed]
WikiGenes - Universities